Clinical trial
Study Using the Medpulser Electroporation System With Bleomycin to Treat Head…
NCT00198263 · Inovio Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00198263 |
|---|---|
| Title | Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer |
| Official title | An Open-Label Study Using the Medpulser® Electroporation System to Treat Head and Neck Cancer |
| Lead sponsor | Inovio Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Combination Product |
| Interventions | Medpulser Electroporation with Bleomycin |
| Enrollment | 95 |
| Start date | Jan 1, 2004 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 3, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: